Island Pharmaceuticals groundbreaking PROTECT trial advances with full enrolment in Phase 2b, aiming to combat dengue fever through the repurposed antiviral ISLA-101.
BlinkLab’s AI-powered diagnostic tool is set to revolutionise autism diagnosis by accelerating early detection and addressing gender disparities through cutting-edge clinical trials.
A second retail growth pillar continues to rise in tune with digital sales as CCO gets on the expansion path across Australia and the US.
Pivotal trials which could position an Australian therapeutic as a leading candidate in the fight against stroke continue on pace.
Immuron heads toward a third set of Phase 2 clinical studies after pre-clinical success against a deadly infection.
Kava sales appear to be getting CCO close to breakeven after a massive jump in consecutively building online buys.
A rising trend of Calmer Co Kava sales goes in tune with a global megatrend of turning from alcohol to healthier alternatives.
More preclinical data showing efficacy on an animal model has Argenica further on the path toward clinical trials for traumatic brain injury.
ARG-007 trials will continue unmodified across ten Australian hospitals after no adverse events in the first five patients.
A range of Osteopore products are cleared for market as the regenerative medicine company looks to stamp its place in a fast-growing industry.